XORTX Therapeutics, Inc. (XRTX)

1.41 -0.44 (-23.78%) USD  |  NASDAQ  |  Oct 09, 16:00
1.47 +0.06 (+4.26%) After-Hours: 20:00
More

XORTX Therapeutics EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for XRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2022. Start Trial.
Date Value
September 18, 2025 --
February 25, 2025 --
January 04, 2024 --
May 08, 2023 --
April 24, 2023 --
April 10, 2023 --
January 19, 2023 --
Date Value
November 18, 2022 --
October 27, 2022 --
October 25, 2022 --
August 31, 2022 --
May 04, 2022 --
May 03, 2022 --
April 22, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Lexaria Bioscience Corp. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) --
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade